Contraindicated (one)pentobarbital will decrease the level or impact of cariprazine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is responsible for the development and elimination of cariprazine's active metabolites.pentobarbital will minimize the level or effect of disopyramide by impacting hepatic/intestinal